Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Alexander Nowak is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | CVRX | Buy Now | CVRx | $10.77 | 39.28% | $23 → $15 | Maintains | Buy | Get Alert |
| 05/16/2024 | CELC | Buy Now | Celcuity | $18.79 | 43.69% | $25 → $27 | Assumes | → Buy | Get Alert |
| 05/01/2024 | CVRX | Buy Now | CVRx | $10.77 | 113.56% | $30 → $23 | Assumes | → Buy | Get Alert |
| 05/01/2024 | CDNA | Buy Now | CareDx | $16.14 | -7.06% | $12 → $15 | Upgrade | Hold → Buy | Get Alert |
| 04/24/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $3.30 | 142.46% | → $8 | Assumes | → Buy | Get Alert |
| 04/08/2024 | NTRA | Buy Now | Natera | $112.66 | 3.85% | → $117 | Assumes | → Buy | Get Alert |
| 04/01/2024 | AXDX | Buy Now | Accelerate Diagnostics | $1.13 | -11.5% | $2 → $1 | Maintains | Hold | Get Alert |
| 03/28/2024 | CELC | Buy Now | Celcuity | $18.79 | 33.05% | $20 → $25 | Maintains | Buy | Get Alert |
| 03/21/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $3.30 | 142.46% | $11 → $8 | Maintains | Buy | Get Alert |
| 03/13/2024 | BVS | Buy Now | Bioventus | $6.56 | 37.2% | $6 → $9 | Maintains | Buy | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $31.78 | — | — | Downgrade | Buy → Hold | Get Alert |
| 11/10/2023 | OSA | Buy Now | ProSomnus | — | — | → $1 | Downgrade | Buy → Hold | Get Alert |
| 10/31/2023 | SIEN | Buy Now | Sientra | — | — | → $2 | Downgrade | Buy → Hold | Get Alert |
| 09/05/2023 | LUNG | Buy Now | Pulmonx | $7.75 | 132.26% | → $18 | Initiates | → Buy | Get Alert |
| 06/13/2023 | TNDM | Buy Now | Tandem Diabetes Care | $47.30 | 5.71% | $74 → $50 | Maintains | Buy | Get Alert |
| 05/12/2023 | DRIO | Buy Now | DarioHealth | $1.37 | 483.94% | $14 → $8 | Maintains | Buy | Get Alert |
| 04/03/2023 | BVS | Buy Now | Bioventus | $6.56 | -23.78% | $10 → $5 | Maintains | Hold | Get Alert |
| 04/03/2023 | OSA | Buy Now | ProSomnus | — | — | → $10 | Initiates | → Buy | Get Alert |
| 03/31/2023 | SIEN | Buy Now | Sientra | — | — | $13 → $10 | Maintains | Buy | Get Alert |
| 03/03/2023 | CDNA | Buy Now | CareDx | $16.14 | -44.24% | $26 → $9 | Downgrade | Buy → Hold | Get Alert |
| 02/28/2023 | CDNA | Buy Now | CareDx | $16.14 | 61.09% | $32 → $26 | Maintains | Buy | Get Alert |
| 11/22/2022 | BVS | Buy Now | Bioventus | $6.56 | — | — | Downgrade | Buy → Hold | Get Alert |
| 10/19/2022 | EXAS | Buy Now | Exact Sciences | $47.20 | — | — | Downgrade | Buy → Hold | Get Alert |
| 07/18/2022 | CVRX | Buy Now | CVRx | $10.77 | 39.28% | → $15 | Initiates | → Buy | Get Alert |
| 07/07/2022 | DMAC | Buy Now | DiaMedica Therapeutics | $3.30 | 263.69% | $18 → $12 | Maintains | Buy | Get Alert |
| 03/30/2022 | HTGM | Buy Now | HTG Molecular Diagnostics | — | — | $96 → $36 | Maintains | Buy | Get Alert |
| 03/28/2022 | NMTC | Buy Now | NeuroOne Medical Tech | $1.02 | — | — | Downgrade | Buy → Hold | Get Alert |
| 03/15/2022 | BVS | Buy Now | Bioventus | $6.56 | 357.32% | → $30 | Initiates | → Buy | Get Alert |
| 03/09/2022 | AXDX | Buy Now | Accelerate Diagnostics | $1.13 | 342.48% | → $50 | Downgrade | Buy → Hold | Get Alert |
| 01/07/2022 | HTGM | Buy Now | HTG Molecular Diagnostics | — | — | $60 → $96 | Upgrade | Hold → Buy | Get Alert |
| 01/05/2022 | STXS | Buy Now | Stereotaxis | $2.01 | 447.26% | → $11 | Initiates | → Buy | Get Alert |
| 11/15/2021 | NMTC | Buy Now | NeuroOne Medical Tech | $1.02 | 488.24% | — | Initiates | → Buy | Get Alert |
| 01/11/2021 | VVOS | Buy Now | Vivos Therapeutics | $2.68 | 347.76% | → $300 | Initiates | → Buy | Get Alert |
